D-二苯甲酰酒石酸酐 | 116780-73-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: D-二苯甲酰酒石酸酐
• 英文名称: (3S,4S)-2,5-dioxotetrahydrofuran-3,4-diyl dibenzoate
• 英文别名: [(3S,4S)-4-benzoyloxy-2,5-dioxooxolan-3-yl] benzoate
• CAS: 116780-73-5
• 化学式: C₁₈H₁₂O₇
• 分子量: 340.289
• InChiKey: OXIKRMSPXYQFOT-KBPBESRZSA-N

物化性质

• 沸点：
  533.6±50.0 °C(Predicted)
• 密度：
  1.43±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  25
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  96
• 氢给体数：
  0
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  D-二苯甲酰酒石酸酐 生成 [(3S,4S)-4-benzoyloxy-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-2,5-dioxopyrrolidin-3-yl] benzoate
  参考文献：
  名称：

  COOPER, ROBIN D. G.

  摘要：

  DOI：
• 作为产物：
  描述：

  D-二苯甲酰酒石酸 在 乙酸酐 作用下， 反应 2.0h， 以84%的产率得到D-二苯甲酰酒石酸酐
  参考文献：
  名称：

  METHOD OF PREPARING (3R,4S)-3-ACETAMIDO-4-ALLYL-N-(TERT-BUTYL)PYRROLIDINE-3-CARBOXAMIDE

  摘要：

  提供了一种方便地使用手性羧酸进行选择性结晶分离(3R,4S)-3-乙酰氨基-4-烯丙基-N-(叔丁基)吡咯烷-3-甲酰胺和(3S,4R)-3-乙酰氨基-4-烯丙基-N-(叔丁基)吡咯烷-3-甲酰胺的方法。

  公开号：

  US20180362459A1

文献信息

• Enantioselective oxysulfenylation and oxyselenenylation of olefins catalyzed by chiral Brønsted acids
  作者：Huan Guan、Haining Wang、Deshun Huang、Yian Shi

  DOI：10.1016/j.tet.2012.01.006

  日期：2012.3

  This paper describes Brønsted acid catalyzed enantioselective oxysulfenylation and oxyselenenylation of olefins. Enantiomerically enriched tetrahydrofurans are formed with up to 63% ee with dibenzoyl-d-tartaric acid and its derivatives as catalyst. Chiral β-carboxyl sulfides and selenides have also been obtained with up to 50% and 84% ee, respectively, via enantioselective desymmetrization of thiiranium

  本文介绍了布朗斯台德酸催化的烯烃的对映选择性氧亚磺酰基化和氧硒烯化。对映体富集的四氢呋喃与多达63形成％ee的与二苯甲酰基d -酒石酸以及其作为催化剂的衍生物。在催化量的手性联萘酚衍生的N-三氟乙磷酰胺存在下，通过对ira和硒离子进行对映选择性脱对称，还获得了分别具有高达50％和84％ee的手性β-羧基硫化物和硒化物。
• Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use
  申请人：Gallop A. Mark

  公开号：US20060111325A1

  公开（公告）日：2006-05-25

  Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphonous acid, 3-aminopropylphosphinic acid, and analogs thereof, pharmaceutical compositions comprising acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphonous acid, 3-aminopropylphosphinic acid, and analogs thereof, methods of making prodrugs of 3-aminopropylphosphonous acid, 3-aminopropylphosphinic acid, and analogs thereof, methods of using prodrugs of 3-aminopropylphosphonous acid, 3-aminopropylphosphinic acid, and analogs thereof and pharmaceutical compositions thereof for treating or preventing diseases or disorders such as spasticity or gastroesophageal reflux disease are disclosed. Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphonous acid, 3-aminopropylphosphinic acid, and analogs thereof and sustained release oral dosage forms thereof, which are suitable for oral administration, are also disclosed.

  3-氨基丙基膦酸、3-氨基丙基膦酸和其类似物的酰氧烷基氨基甲酸酯前药，包括3-氨基丙基膦酸、3-氨基丙基膦酸和其类似物的酰氧烷基氨基甲酸酯前药的药物组合物，制备3-氨基丙基膦酸、3-氨基丙基膦酸和其类似物的前药的方法，使用3-氨基丙基膦酸、3-氨基丙基膦酸和其类似物的前药的方法，以及用于治疗或预防痉挛或胃食管反流病等疾病或紊乱的药物组合物。还公开了适用于口服的酰氧烷基氨基甲酸酯前药、3-氨基丙基膦酸、3-氨基丙基膦酸和其类似物的持续释放口服剂型。
• Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
  申请人：Gallop A. Mark

  公开号：US20060111439A1

  公开（公告）日：2006-05-25

  Acyloxyalkyl carbamate prodrugs of 3-aminopropylsulfinic acid and analogs thereof, pharmaceutical compositions of 3-aminopropylsulfinic acid and analogs thereof, methods of making prodrugs of 3-aminopropylsulfinic acid and analogs thereof, methods of using prodrugs of 3-aminopropylsulfinic acid and analogs thereof, and pharmaceutical compositions thereof for treating or preventing diseases or disorders such as spasticity or gastroesophageal reflux disease are disclosed. Acyloxyalkyl carbamate prodrugs of 3-aminopropylsulfinic acid and analogs thereof and sustained release oral dosage forms thereof, which are suitable for oral administration, are also disclosed.

  3-氨基丙磺酸及其类似物的酰氧烷基氨基甲酸酯前药，3-氨基丙磺酸及其类似物的药物组合物，制备3-氨基丙磺酸及其类似物的前药的方法，使用3-氨基丙磺酸及其类似物的前药的方法，以及用于治疗或预防痉挛性或胃食管反流病等疾病或紊乱的药物组合物已被披露。此外，还披露了适用于口服的3-氨基丙磺酸及其类似物的酰氧烷基氨基甲酸酯前药和持续释放口服剂型。
• Phosphorus amino acid analogs as inhibitors of leucine aminopeptidase
  作者：Peter P. Giannousis、Paul A. Bartlett

  DOI：10.1021/jm00392a014

  日期：1987.9

  A variety of phosphorus amino acid and dipeptide analogues have been synthesized and evaluated as inhibitors of the metalloenzyme leucine aminopeptidase from porcine kidney. Two phosphonate dipeptides were found to be modest inhibitors of the enzyme (8e, Ki = 58 microM; 8h, Ki = 340 microM). The phosphinic acid (17-OH) and phosphinamide (17-NH2) analogues related to bestatin were prepared by condensation

  已经合成了多种磷氨基酸和二肽类似物，并被评价为来自猪肾脏的金属酶亮氨酸氨基肽酶的抑制剂。发现两种膦酸酯二肽是该酶的适度抑制剂（8e，Ki = 58 microM； 8h，Ki = 340 microM）。与贝斯汀相关的次膦酸（17-OH）和次膦酰胺（17-NH2）类似物是通过使次膦酸酯氨基酸衍生物11通过三价亚膦酸酯12与亮氨酸异氰酸酯衍生物13缩合而制备的。在抑制LAP方面无异常（17-O-，Ki = 56 microM； 17-NH2，Ki = 40 microM）。还评估了一系列简单的（α-氨基烷基）膦酸和-次膦酸，发现最有效的抑制剂是L-Leu和L-Phe [R] -3e的膦酸类似物，Ki = 0.23 microM; （R）-3h，Ki ＝0.42μM）。对于（R）-3e（kon = 400 +/- 55 M-1 s-1）和（R）-3h（kon = 445 +/- 50 M-1
• An improved process of separation of<i>R-</i>and<i>S</i>-timolol
  作者：Erika Várkonyi-Schlovicskó、Kálmán Takács、István Hermecz

  DOI：10.1002/jhet.5570340357

  日期：1997.5

  Diastereomeric timolol tartrates 4 are obtained in a one-pot synthesis from the racemic base 2 and optically active O,O-diacetyl- or O,O-dibenzoyltartaric anhydrides 3, as only one of the diastereomers precipitates from acetone solution. Acidic hydrolysis as the corresponding 4 leads to timolol in high yield and optical purity.

  一锅合成中，由外消旋碱2和旋光的O，O-二乙酰基-或O，O-二苯甲酰基酒石酸酐3获得非对映异构的酒石酸叔丁醇酒石酸酯4，因为仅一种非对映异构体从丙酮溶液中沉淀出来。酸性水解为相应的4可获得高产量和光学纯度的噻吗洛尔。